Effect of a Patient Support Program for Idiopathic Pulmonary Fibrosis Patients on Medication Persistence: A Retrospective Database Analysis

por Near, Aimee M., Burudpakdee, Chakkarin, Viswanathan, Shilpa, Kaila, Shuchita
Publicado 2021

Real-world patient characteristics and treatment outcomes among nontransplanted multiple myeloma patients who received Bortezomib in combination with Lenalidomide and Dexamethasone...

por Medhekar, Rohan, Ran, Tao, Fu, Alex Z., Patel, Sharmila, Kaila, Shuchita
Publicado 2022

Development and validation of a predictive model to identify patients at risk of severe COPD exacerbations using administrative claims data

por Annavarapu, Srinivas, Goldfarb, Seth, Gelb, Melissa, Moretz, Chad, Renda, Andrew, Kaila, Shuchita
Publicado 2018

Real-world Duration of Use and Dosing Frequency of Daratumumab in Patients With Multiple Myeloma in the United States

por Fonseca, Rafael, Chinaeke, Eric E., Gupta-Werner, Niodita, Fu, Alex Z., Kaila, Shuchita
Publicado 2023

Spirometry evaluation to assess performance of a claims-based predictive model identifying patients with undiagnosed COPD

por Moretz, Chad, Annavarapu, Srinivas, Luthra, Rakesh, Goldfarb, Seth, Renda, Andrew, Shaikh, Asif, Kaila, Shuchita
Publicado 2019

PB2110: PREDICTORS OF FRONTLINE (FL) DOUBLET OR TRIPLET REGIMEN USE AMONG TRANSPLANT-INELIGIBLE (TIE) PATIENTS (PTS) WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM) USING A MACHINE LE...

por Pianko, Matthew J., Gupta-Werner, Niodita, Emond, Bruno, Lefebvre, Patrick, Lafeuille, Marie-Helene, Cortoos, Annelore, Kaila, Shuchita
Publicado 2023

COPD exacerbation frequency and its association with health care resource utilization and costs

por Dhamane, Amol D, Moretz, Chad, Zhou, Yunping, Burslem, Kate, Saverno, Kim, Jain, Gagan, Renda, Andrew, Kaila, Shuchita
Publicado 2015

Initiation of triple therapy maintenance treatment among patients with COPD in the US

por Simeone, Jason C, Luthra, Rakesh, Kaila, Shuchita, Pan, Xiaoyun, Bhagnani, Tarun D, Liu, Jieruo, Wilcox, Teresa K
Publicado 2016

Association between adherence to medications for COPD and medications for other chronic conditions in COPD patients

por Dhamane, Amol D, Schwab, Phil, Hopson, Sari, Moretz, Chad, Annavarapu, Srinivas, Burslem, Kate, Renda, Andrew, Kaila, Shuchita
Publicado 2016

Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population

por Schwab, Phil, Dhamane, Amol D, Hopson, Sari D, Moretz, Chad, Annavarapu, Srinivas, Burslem, Kate, Renda, Andrew, Kaila, Shuchita
Publicado 2017

Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: a real-world chart review study

por ATRASH, Shebli, THOMPSON-LEDUC, Philippe, TAI, Ming-Hui, KAILA, Shuchita, GRAY, Kathleen, GHELERTER, Isabelle, LAFEUILLE, Marie-Hélène, LEFEBVRE, Patrick, ROSSI, Adriana
Publicado 2021

Correction to: Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: a real-world chart review study

por Atrash, Shebli, Thompson-Leduc, Philippe, Tai, Ming-Hui, Kaila, Shuchita, Gray, Kathleen, Ghelerter, Isabelle, Lafeuille, Marie-Hélène, Lefebvre, Patrick, Rossi, Adriana
Publicado 2021

Development and Validation of a Predictive Model to Identify Individuals Likely to Have Undiagnosed Chronic Obstructive Pulmonary Disease Using an Administrative Claims Database

por Moretz, Chad, Zhou, Yunping, Dhamane, Amol D., Burslem, Kate, Saverno, Kim, Jain, Gagan, Devercelli, Giovanna, Kaila, Shuchita, Ellis, Jeffrey J., Hernandez, Gemzel, Renda, Andrew
Publicado 2015

P1685: PATIENTS’ PREFERENCES FOR MULTIPLE MYELOMA (MM) TREATMENT INITIATION AND DISCONTINUATION IN THE US

por Binder, Adam F., Shah, Urvi A., Gupta-Werner, Niodita, Lu, Hui, Venkatraman, Malavika, Whitty, Jennifer, Khare, Vipin, Costa, Olivia, Kaila, Shuchita, Lipe, Brea C.
Publicado 2023

PB2128: CLINICAL CONSENSUS ON FIRST-LINE (1L) TREATMENTS FOR TRANSPLANT-INELIGIBLE (TIE) PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM): DELPHI PANEL OF US HEMATOLOGISTS AND...

por Fonseca, Rafael, Rossi, Adriana, Voelker, Jennifer, Homan, Trevor, Kaila, Shuchita, Medhekar, Rohan, Wilcock, Jessica, Karakusevic, Anna, Cochrane, James, Bridge, Daisy, Perry, Richard, Davies, Faith E
Publicado 2023

Clinical Administration Characteristics of Subcutaneous and Intravenous Administration of Daratumumab in Patients With Multiple Myeloma at Mayo Clinic Infusion Centers

por Soefje, Scott A., Carpenter, Corinne, Carlson, Katherine, Awasthi, Samir, Lin, Thomas S., Kaila, Shuchita, Tarjan, Daniel, Kayal, Nikhil, Kirkup, Christian, Wagner, Tyler E., Gray, Kathleen S., Kumar, Shaji
Publicado 2023

Daratumumab Improves Depth of Response and Progression-free Survival in Transplant-ineligible, High-risk, Newly Diagnosed Multiple Myeloma

por Jakubowiak, Andrzej J, Kumar, Shaji, Medhekar, Rohan, Pei, Huiling, Lefebvre, Patrick, Kaila, Shuchita, He, Jianming, Lafeuille, Marie-Hélène, Cortoos, Annelore, Londhe, Anil, Mavros, Panagiotis, Lin, Thomas S, Usmani, Saad Z
Publicado 2022